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Bacopa monniera extract (CDRI-08; BME) has been known to improve learning and
memory, and understanding the molecular mechanisms may help to know its specificity.
We investigated whether the BME treatment alters the methylation status of reelin
and brain-derived neurotropic factor (BDNF) to enhance the memory through the
interaction of N-methyl-D-aspartate receptor (NMDAR) with synaptic proteins. Rat pups
were subjected to novel object recognition test following daily oral administration of
BME (80 mg/kg) in 0.5% gum acacia (per-orally, p.o.; PND 15–29)/three doses of
5-azacytidine (5-azaC; 3.2 mg/kg) in 0.9% saline (intraperitoneally, i.p.) on PND-30.
After the behavioral test, methylation status of reelin, BDNF and activation of NMDAR,
and its interactions with synaptic proteins were tested. Rat pups treated with BME/5-
azaC showed higher discrimination towards novel objects than with old objects during
testing. Further, we observed an elevated level of unmethylated DNA in reelin and BDNF
promoter region. Up-regulated reelin along with the splice variant of apolipoprotein E
receptor 2 (ApoER 2, ex 19) form a cluster and activate NMDAR through disabled
adopter protein-1 (DAB1) to enhance BDNF. Observed results suggest that BME
regulate reelin epigenetically, which might enhance NMDAR interactions with synaptic
proteins and induction of BDNF. These changes may be linked with improved novel
object recognition memory.
Keywords: Bacopa monniera, Novel object recognition, reelin, apolipoprotein E receptor 2 (ApoER 2), N-methyl-
D-aspartate receptor (NMDAR), brain-derived neurotropic factor (BDNF)
INTRODUCTION
Long-term memory formation requires fine tuned cellular signaling coordination with
transcriptional and translational regulations of gene expression (Hawk and Abel, 2010). Epigenetic
mechanisms specifically control transcription through many ways, among which DNA methylation
being common (Levenson et al., 2006; Blaze and Roth, 2013; Morris and Monteggia, 2014).
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This process involves DNA methyltransferases (DNMTs) that
mediates de novo methylation within DNA and alters the
chromatin structure (Shilatifard, 2006; Lubin, 2011; Nabel and
Kohli, 2011); which directly controls transcription. Several
studies have reported that DNA methylation/demethylation in a
specific promoter region of reelin and brain-derived neurotrophic
factor (BDNF) dictates the transcriptional activity thereby
critically regulating synaptic plasticity, learning, and memory
(Miller and Sweatt, 2007; Levenson et al., 2008; Lubin et al., 2008;
Mizuno et al., 2012; Sui et al., 2012). Reelin is a large secreted
glycoprotein richly expressed at hippocampus by a subset of
γ-amino butyric acid (GABA)-ergic interneurons (Pesold et al.,
1998; Abraham and Meyer, 2003; Ramos-Moreno et al., 2006).
Reelin exerts its effects through two receptors: apolipoprotein
E receptor 2 (ApoER 2) and very-low-density lipoprotein
receptors (VLDLR) (Weeber et al., 2002; Strasser et al.,
2004). ApoER 2 expression in hippocampus promotes neuronal
signaling and induction of long-term potentiation (LTP) (Barr
et al., 2007). However, only the spliced variant of ApoER 2 with
exon 19 (ex 19) (Beffert et al., 2005) interacts with NPxY domain
of adopter protein disabled-1 (DAB1) to elicit intracellular
signaling (Howell et al., 1999; Benhayon et al., 2003; Beffert et al.,
2006). Activation/phosphorylation of DAB1 (p-DAB1) by reelin-
induced receptor cluster, depends on Src family tyrosine kinases
(SFKs). The activated p-DAB1 in turn activates SFKs (Strasser
et al., 2004; Kuo et al., 2005). Subsequently, activated SFKs
phosphorylate the subunits of N-methyl-D-aspartate (NMDA;
NR2A/NR2B) receptors (Yu et al., 1997; Chen et al., 2005; Mota
et al., 2014). Further, the activated NMDA receptors target the
activation of BDNF (Lubin et al., 2008). On the other hand,
subunits of NMDA receptor directly interact with post-synaptic
density protein-95 (PSD-95′ Hoe et al., 2006), and induces LTP
and long-term memory (LTM).
Bacopa monniera extract has been traditionally used
in Ayurvedic medicine to improve learning and memory.
B. monniera extract contains triterpene saponins, which have
been named bacosides and bacopasaponins. The major chemical
entity shown responsible for neuropharmacological effects of
B. monniera are bacoside A (bacogenins A1, A2, A3, and A4)
and bacoside B (Pubmed C ID: 53398644); the latter differs only
in optical rotation and may probably be an artifact produced
during the process of isolating bacoside A (Chatterji et al.,
1963, 1965; Basu et al., 1967). CDRI-08 mentioned as BME
in this article is a bacoside-enriched standardized extract of
B. monniera (CDRI-08, contains 55 ± 5% bacosides). Earlier
studies demonstrate that CDRI-08 significantly improves the
cognitive performance in healthy human participants (Downey
et al., 2013; Benson et al., 2014); and in elders and patients with
neurodegenerative disorder (Barbhaiya et al., 2008; Calabrese
et al., 2008; Stough et al., 2013). Bacosides present in the CDRI-08
are non-polar glycosides, which possibly cross the blood–brain
barrier (BBB) by lipid mediated passive diffusion (Pardridge,
1999); and its biodistribution in brain has been confirmed by
radiopharmaceuticals (De et al., 2008). Earlier, in rat model, we
found that oral treatment of BME elevates the level of serotonin
(5-hydroxytryptamine, 5-HT), activates 5-HT3A receptor (Rajan
et al., 2011), and regulates cyclic adenosine monophosphate
(cAMP) response element binding (CREB) protein through
microRNA (miR)-124 (Preethi et al., 2012). Subsequently, we
reported that BME regulates extracellular signal-regulated kinase
(ERK)/CREB cascade and BDNF through regulation of histone
acetylation and protein phosphatases to improve hippocampal
memory (Preethi et al., 2014). In the present study, first we tested
whether the treatment of BME/DNMT inhibitor (5-azacytidine
and 5-azaC) improves novel object recognition. Second, we
examined whether BME/5-azaC treatment alters methylation
status of reelin and BDNF, and its effect on NMDA (NR2A)
receptor interaction with synaptic proteins.
MATERIALS AND METHODS
Animals
Wistar rat pups both male and female (Rattus norvegicus; B.wt:
19.6 ± 0.6 g on PND-15) were housed in a standard laboratory
cage (43 × 27 × 15 cm) with paddy husk as a bedding
material. Rat pups were maintained at animal house under
controlled environmental condition [12-h light/dark cycle (7:00–
19.00); temperature: 22 ± 2◦C; humidity: 50 ± 5%)] with ad
libitum access to food and water. Protocols for animal use were
performed following the guidelines of Institutional Animal Ethics
Committee (BDU/IAEC/2014/OE/08/Dt. 18.03.2014), ensuring
that number of animals and pain was kept to a minimum.
Drugs and Treatment
Standardized extract of B. monniera (CDRI-08 with 55 ± 5%
bacosides) (Gifted by Lumen Marketing Company, Chennai,
India), was dissolved in 0.5% gum acacia (Hi-Media Laboratories
Pvt. Ltd, Mumbai, India). The DNA methyltransferase (DNMT)
inhibitor, 5-azacytidine (5-azaC; ≥ 98%, Sigma–Aldrich, India)
was dissolved in 0.9% saline. Drugs were prepared freshly on
the day of administration (10:00–11:00 h) and drugs were
administered to rat pups during their brain growth spurt
period (Dobbing and Sands, 1979). Rat pups from different
litters which attained the age of postnatal day (PND)-14 were
randomly assigned into three groups: (i) control group (Con,
n = 24) received vehicle solution 0.5% gum acacia, per-
orally (p.o.) from PND 15–29 and three doses of 0.9% saline
intraperitoneally (i.p.) on PND-30 (0, 5, and 23 h), (ii) BME
group (BME, n = 24) received 80 mg/kg of CDRI-08 in
0.5% gum acacia (p.o.) from PND 15–29 (Rajan et al., 2011)
and three doses of 0.9% saline (i.p.) on PND-30 (0, 5, and
23 h), (iii) 5-azaC group (5-azaC, n = 24) received 0.5% gum
acacia (p.o.) from PND 15–29 and three doses of 3.2 mg/kg
of 5-azaC (i.p.) on PND-30 (0, 5, and 23 h) (Sales et al.,
2011).
Novel-Object Recognition Test
The apparatus used for novel-object recognition (NOR) test
was conducted in circular open-field board (82 cm diameter)
made of wood, coated black surrounded by a wall of 32 cm
height (Barbosa et al., 2013). Two sets of objects (Cuboids and
Spherical objects) were used. The cuboids (13 × 10 × 10 cm)
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FIGURE 1 | Effect of BME/5-azaC on training at novel object
recognition test. (A) Con/BME/5-azaC groups spent equal time and
showed no discrimination for objects during training 1, (B) and training 2. Data
were shown as mean ± SEM, there was no significant difference between
comparisons (Con verses BME; Con verses 5-azaC; BME verses 5-azaC).
were made of plaster of paris and painted with blue color (non-
toxic children water color). The plastic balls (radius: 26 cm) were
green in color and filled with sand to ensure that animals cannot
displace them. The apparatus and objects were cleaned with 75%
ethanol after each behavior session. The sessions were recorded
by a video camera (Sony megapixel 12.1, Full HD 1080) placed
at a distance of 150 cm above the apparatus. In novel object
recognition test, rodents’ innate habit of exploring novel object
in their environment has been utilized to evaluate their memory
(Ennaceur and Delacour, 1988). Exploration time was scored
as when the rat nose was touching the object or orienting its
head towards the object within a distance of 1 cm. The relative
exploration time was recorded and expressed by a discrimination
index [D.I. = (tnovel − told)/(tnovel + told) × 100%] as reported
earlier (Stefanko et al., 2009). Mean exploration times were
calculated and the discrimination indexes between groups were
FIGURE 2 | Effect of BME/5-azaC on novel object recognition test.
(A) Con/BME/5-azaC group rats spent more time(s) around novel object than
old objects. Whereas, BME/5-azaC groups spent significantly more time
around novel object compared to control group. (B) BME/5-azaC treated
groups displayed significantly higher DI (%) for novel object compared to
control group. Data were shown as mean ± SEM, asterisk indicates
significant difference (∗∗P < 0.01; ∗∗∗P < 0.001). Comparisons between
groups are represented as a = Con verses BME; b = Con verses 5-azaC; and
c = BME verses 5-azaC; $ = Con old verses novel; # = BME old verses
novel; @ = 5-azaC old verses novel.
compared. Rat was allowed to freely explore the experimental
area in groups (n = 3) on PND-28, 29 and individually on
PND-30 for 10 min. On PND-31, all animals were trained for
two sessions (5 min each session) with an interval of 1 h.
During training, rats were exposed to four identical objects.
On PND-32 during retention session, two new objects were
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placed in the position of any two old objects and the exploration
behavior of each rat was recorded for 5 min (Barbosa et al.,
2013).
Tissue Collection, RNA and Protein
Isolation
After the NOR test, animals representing each group (n = 6)
were euthanized, and the hippocampus tissue was dissected as
described by Glowinski and Iversen (1996) for the preparation
of RNA and protein. Total RNA was isolated from hippocampus
tissue samples using TRIzol (Merck Specialties Pvt. Ltd., India),
according to the manufacturer’s instructions and stored with
RNase inhibitor (Merck Specialties Pvt. Ltd, India) at −80◦C.
The hippocampus tissue samples were homogenized in ice-
cold lysis buffer (150 mM NaCl, 50 mM Tris–HCl pH 7.5,
5 mM EDTA, 0.1% v/v NP-40, 1 mM DTT, 0.2 mM sodium
orthovanadate, 0.23 mM PMSF) and 10 µl/ml protease inhibitor
cocktail (Sigma–Aldrich, USA). The homogenates were kept
on ice for 30 min and then centrifuged at 10,000 × g
for 30 min at 4◦C. The clear supernatants were collected
in a fresh tube and centrifuged again at 12,000 × g for
15 min at 4◦C. The final supernatants were collected and
stored as aliquots, in order to avoid repeated freeze–thaw of
the samples and were stored at −80◦C. The concentration
of each protein sample was quantified by measuring the
absorbance at 595 nm using Biophotometer plus (Eppendorf Inc.,
Germany).
DNA Methylation Assay
Individuals representing each group (n = 6) were euthanized
and DNA was isolated from hippocampus tissue (UltraClean
R©
Tissue & Cells DNA isolation kit, Cat no. 12334-50, MO BIO
laboratories, Inc., USA) and processed for bisulfite modification
(EpiTect Bisulfite kit, Qiagen, Cat no. 59104).
Quantitative Real-Time PCR (qRT-PCR)
The qRT-PCR was performed using real-time reaction mixture
(SSoAdvancedTM SYBR
R©
green supermix, Bio-Rad Laboratories,
Inc., USA) with specific primers (50 pmol/µl) and DNA
(0.4 ng/µl)/ primers (200 pmol/µl) and cDNA (0.2 µg/µl) in
CFX-96 TouchTM Real-time PCR (RT-PCR) Detection System
(Bio-Rad Laboratories, Inc., USA).
The detection of unmethylated DNA in the gene promoter was
performed using the specific primers for reelin (For 5′-TG
TTAAATTTTTGTAGTATTGGGGATGT-3′; Rev 5′-TCCTTA
AAATAATCCAACAACACACC-3′) and BDNF (CpG island 1)
(For 5′-GGGTAGTGATTTT GGGGAGGAAGTAT-3′; Rev 5′-C
AACCTCTATACACAACTAAATCCACC-3′) (Sui et al., 2012).
Reactions were performed with the following cycling
conditions: 95◦C for 3 min, 40 cycles of 95◦C for 15 s, 62.6◦C
(reelin)/65.5◦C (BDNF) for 1 min and 73.5◦C (reelin)/72
◦C (BDNF) for 15 s. Detection of methylated DNA was
performed using specific primers for reelin (For 5′-GGTGTTA
AATTTTTGTAGTATTGGGGAC-3′; Rev 5′-TCCTTAAAAT
AATCCAA CAACACGC-3′) and CpG island 1 of BDNF
(For 5′-GTA GCGATTTTGGGGAGGAAGTAC-3′; Rev (5′-
CAACCTCTATACGCGACTAAATCCG-3′) (Sui et al., 2012).
Reactions were performed with the following cycling conditions:
95◦C for 3 min, 40 cycles of 95◦C for 15 s, 60◦C (reelin)/61◦C
(BDNF) for 1 min and 72◦C (reelin)/74◦C (BDNF) for 15 s. To
verify specificity, the final product was electrophoresed on 2%
agarose gel stained with ethidium bromide (0.5 µg/ml), and
amplification and band intensity was examined in ChemiDoc
XR + System with image lab 2 (Bio-Rad Laboratories, Inc.,
USA).
To examine the expression level of mRNA, total RNA
(2.0 µg/sample) was reverse transcribed into cDNA using
random/oligo-dT primers (iScript cDNA Synthesis Kit, Bio-
Rad Laboratories Inc., USA). The expression level of specific
genes were estimated using specific primers reelin (For: 5′-
AAACTACAGCGGGTGGAACC-3′ and Rev: 5′-ATTTGAGG
CATGA CGGACCTATAT-3′) (Sui et al., 2012)/BDNF (For:
5′-GTAAACGTCCACGGACAAG-3′ and Rev: 5′-TATGGTTTT
CTTCGTTGGGC-3′), Total ApoER 2 (For: 5′-AGTGTCCCG
ATGGC TCTGAC-3′ and Rev: 5′-CAGCTTAACTTCTCGGC
AGGA-3′), ApoER 2 (ex19) For: 5′GCC CTCAAGGAGCTTTTT
GTC-3′ and Rev: 5′-AGGGTTCTTCGGGAGTTGGT-3′), Apo
ER 2 (1) For: 5′-CAGTGTACAGGAAAACGACAGAAGA-3′
and Rev: 5′-TGCCACTCGTGCG GG-3′ (Beffert et al., 2005)
with Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
(For: 5′-AACATCATCCCTGCATCCAC-3′ and Rev: 5′-AGG
AACACGGAAGGCCATGC-3′) as internal control. Conditions
for the RT-PCR reactions were as follows: initial denaturation
at 94◦C for 3 min followed by denaturation at 94◦C for
5 s, annealing (64.5◦C for reelin, 60◦C for BDNF, 55◦C
for total ApoER 2, 60◦C for ApoER 2 (ex19), 57◦C for
ApoER 2 (1) and 56◦C for GAPDH) for 5 s, extension at
72◦C for 5 s. The amplification of the single PCR product
was confirmed by monitoring the dissociation curve followed
by melting curve analysis. Each reaction was performed in
triplicates and normalized with internal control GAPDH. The
data were presented as mean fold change relative to the
control group (CFX ManagerTM version 2 software; CFX-96
TouchTM RT-PCR Detection System Bio-Rad Laboratories, Inc.,
USA).
Western Blot Analysis
Equal concentrations (30 µg) of proteins were resolved on
9% SDS–polyacrylamide gel. The separated proteins were
transferred electrophoretically onto polyvinylidene difluoride
(PVDF) membrane (Merck Millipore, India) using a semi-dry
western apparatus (SD 20; Cleaver Scientific Ltd, UK). The
membranes were blocked and incubated at 4◦C for 9 h with
one of the following specific primary antibodies (Santa-Cruz
Biotechnology, Cell signaling solutions, USA): rabbit polyclonal
anti-BDNF (N-20) [SC-546, 1:500], anti-PSD-95 [SC-28941,
1:200], anti-Dab1 [Cat #3328, 1:1000], anti-Phospho-Dab1 [Cat
#3327, 1:1000], anti-NMDAR2A [Cat #4205, 1:1000], anti-
NMDAR2B [Cat #4207, 1:1000] antibodies, mouse monoclonal
anti-p-Tyr antibody [SC-7020, 1:300] and rabbit polyclonal anti-
β-actin antibody (SC-130656; 1:200) was used as control for
each sample. The membrane-bound antibodies were detected
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FIGURE 3 | Effect of BME/5-azaC on regulation of DNA methylation in the reelin promoter and reelin expression. BME/5-azaC treatment significantly (A)
increased unmethylated DNA, (B) and decreased methylated DNA in reelin promoter region relative to control group. (C) reelin mRNA was significantly higher in
BME/5-azaC treated groups compared to control group. Data were shown as mean ± SEM, asterisk indicates significant difference (∗P < 0.05; ∗∗P < 0.01;
∗∗∗ P < 0.001). Comparisons between groups are represented as a = Con verses BME; b = Con verses 5-azaC; and c = BME verses 5-azaC.
FIGURE 4 | Effect of BME/5-azaC on ApoER 2 splicing of variants. (A) BME/ 5-azaC treatment significantly increased the level of ApoER 2 (ex 19) mRNA, (B)
and decreased levels of ApoER 2 (1) exon mRNA compared to control group. Data were shown as mean ± SEM, asterisk indicates significant difference
(∗∗P < 0.01; ∗∗∗P < 0.001). Comparisons between groups are represented as a = Con verses BME; b = Con verses 5-azaC; and c = BME verses 5-azaC.
by incubating for 3 h at 4◦C with alkaline phosphatase (ALP)
conjugated either with goat anti-rabbit (Cat #621100180011730,
MERCK, 1:2000), goat anti-mouse (Cat #621100480011730,
MERCK, 1:2000) secondary antibody. Subsequently alkaline
phosphatase activity was detected with 5-bromo-4-chloro-3-
indolyl phosphate di-sodium salt (BCIP)/nitroblue tetrazolium
chloride (NBT) (HIMEDIA, Mumbai, India) according to
the manufacturer’s instructions. Images were acquired with a
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FIGURE 5 | Effect of BME/5-azaC on induction and phosphorylation of
DAB1 in hippocampus. (A) Western blots showing the immunoreactivity to
anti-total DAB1, and anti-phosphorylated DAB1. (B) BME/5-azaC treatment
increased levels of p-DAB1 compared to control. Data were shown as
mean ± SEM, asterisk indicates significant difference (∗P < 0.05;
∗∗∗P < 0.001). Comparisons between groups are represented as a = Con
verses BME; b = Con verses 5-azaC; and c = BME verses 5-azaC.
ChemiDoc XR + System (Bio-Rad Laboratories, Inc., USA),
and optical density of trace quantity for each band was
measured using Image Lab 2 software (Bio-Rad Laboratories,
Inc., USA). The trace quantity of each bands were normalized
with β-actin bands, following that fold changes were calculated
by dividing normalized values of BME/5-azaC groups by control
groups.
Co-immunoprecipitation
Spin columns were packed with AminoLink Plus Coupling
resin slurry (50 µl) and washed with provided buffer, then
20 µg of anti-rabbit NR2A antibody (Cat #4205, adjusted to
200 µl volume with 1× coupling buffer) was added in the
column and incubated on a rotator at room temperature
for 2 h to immobilize antibodies. For Co-IP, 200 µg of
protein lysates from each groups Con/BME/5-azaC were
immunoprecipitated with NR2A antibody in immobilized spin
columns overnight at 4◦C. Immunoprecipitated protein was
eluted using elution buffer. The complete Co-IP experiment
performed following the instructions provided with the
kit (Catlogue no. 26149, Pierce Co-Immunoprecipitation
Kit, Thermofisher, IL, USA). Equal volume of NR2A
precipitated protein from each sample elutes was analyzed
by immunoblotting using a SFK (SC-7020, 1:300) and
PSD-95 (SC-28941, 1:200) antibody. Immunoblotting was
performed following the procedure reported in the western blots
section.
Statistics
Data were presented as a mean ± standard error of the
mean (SEM) and plotted with KyPlot (ver 1.0) for graphical
representation. For behavioral analysis (NOR), multivariate
ANOVA was performed to test the effect of factors (training
sessions, objects) and their interactions during training. One-
way analysis of variance (ANOVA) and Two-way analysis of
variance (Two-way ANOVA) were used to assess the significance
between groups and groups × objects interactions during
testing respectively. Post hoc Bonferroni test was used to
examine the difference between groups. Association between the
recognition memory (DI) and methylation/unmethylation DNA
was estimated using Pearson correlations (SPSS, ver.15). For
expression data, One-way analysis of variance (ANOVA) was
used to observe the significance between groups. Differences were
considered significant if P < 0.05.
RESULTS
BME Improves Novel Object Recognition
Novel object recognition test was performed to examine the
effect of BME on hippocampus dependent long-term memory.
At first, rat pups from experimental groups (Con, BME, 5-
azaC) were subjected to training. Multivariate ANOVA analysis
revealed that there was no significant difference between training
sessions [Wilks’ λ = 0.953; F = 1.016; P = 0.392], objects
[Wilks’ λ = 0.916; F = 0.614; P = 0.784] and interaction of
training sessions × objects [Wilks’ λ = 0.9356; F = 0.466;
P = 0.895]. Further, our analysis showed that the time spent
by rat pups exploring the objects did not differ significantly
between training sessions [Con: F(1,71) = 0.493, P = 0.493;
BME: F(1,71) = 2.48, P = 0.120; 5-azaC: F(1,71) = 0.096,
P = 0.758], objects [Con: F(3,71) = 0.295, P = 0.829;
BME: F(3,71) = 0.995, P = 0.401; 5-azaC: F(3,71) = 0.691,
P = 0.561] and interaction of training sessions × objects
[Con: F(3,71) = 0.672, P = 0.572; BME: F(3,71) = 0.446,
P = 0.721; 5-azaC: F(3,71) = 0.284, P = 0. 837] (Figures 1A,B;
Supplementary Table S1). During retention test, Con/BME/5-
azaC groups spent significantly more time around novel objects
[Con: F(2,17) = 31.825, P < 0.001; BME: F(2,17) = 109.794,
P < 0.001; 5-azaC: F(2,17) = 116.415, P < 0.001] than old
objects. Whereas, BME [F(2,17) = 15.399, P < 0.01]/ 5-azaC
[F(2,17) = 11.681, P < 0.01] group rat pups spent significantly
more time around novel objects than control group. Further
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FIGURE 6 | Effect of BME/5-azaC on level of NMDAR subunits. (A) Western blots showing the immunoreactivity to anti-NR2A, anti-NR2B. (B) BME/5-azaC
treated groups showed comparatively increased level of NR2A, (C) and NR2B. (D) NR2A/NR2B ratio was significantly more in BME/5-azaC groups than control
group. Data were shown as mean ± SEM, asterisk indicates significant difference (∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001). Comparisons between groups are
represented as a = Con verses BME; b = Con verses 5-azaC; and c = BME verses 5-azaC.
two-way ANOVA revealed that there was a significant difference
across the treatment groups [F(2,53) = 5.279, P < 0.01]
and objects [F(1,53) = 245.476, P < 0.001] in novel object
exploration time, and treatment groups × objects interaction
[F(2,53) = 12.43, P < 0.001]. In addition, Bonferroni post
hoc test confirmed that the novel object exploration time was
statistically higher in BME (P < 0.05) and 5-azaC (P < 0.05)
compared to control (Figure 2A). BME/5-azaC treated group
spent more time to explore the novel objects compared to
old objects. Discrimination indexes were greater than zero for
the study groups, where BME [F(1,17) = 36.56, P < 0.001]
and 5-azaC [F(1,17) = 21.648, P < 0.001] group showed
significantly higher DI than control group. While comparing
BME and 5-azaC, there was no significant difference between
them [F(1,17) = 4.985, P = 0.040] (Figure 2B). Our results
demonstrated that BME treatment effectively establish long-term
memory for the familiar object, which was comparable to 5-azaC
treatment.
Effect of BME on Methylation of Reelin
Promoter and Its Expression
To test whether the improvement in NOR by methylation
status of reelin is due, atleast in part by BME treatment,
we determine the effect of BME on methylation status of
CpG island present in reelin promoter. We found that BME
treatment induced a significant effect on methylation status of
reelin and its expression. Our analysis showed that significant
increase in unmethylated reelin DNA levels associated with
BME [F(1,5) = 78.132, P < 0.001] and 5-azaC treatment
[F(1,5) = 12.706, P < 0.05] than control. There were no
changes in the unmethylation level of reelin DNA between
BME and 5-azaC groups [F(1,5) = 0.667, P = 0.460]
(Figure 3A). Simultaneously, the level of methylated reelin
DNA decreased in BME [F(1,5) = 30.867, P < 0.01] and
5-azaC [F(1,5) = 18.16, P < 0.05] compared to control
group. Whereas, there was no significant difference between
BME and 5-azaC groups [F(1,5) = 5.280, P = 0.083]
(Figure 3B). Interestingly, demethylation of reelin promoter
resulted in significant up-regulation of reelin expression in
BME [F(1,11) = 28.79, P < 0.001] and 5-azaC groups
[F(1,11) = 17.98, P < 0.01] compared to control group, but there
was no significant difference between BME and 5-azaC groups
[F(1,11) = 4.299, P= 0.065] (Figure 3C). Subsequently, we found
a significant positive correlation between recognition memory
(discrimination index; DI) and unmethylated reelin DNA (BME:
r = 0.973, P < 0.001; 5-azaC: r = 0.878, P < 0.01), and a
negative correlation between DI and methylated reelin DNA
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FIGURE 7 | Effect of BME/5-azaC on interaction of NR2A with synaptic proteins. (A) Western blots showing immunoreactivity to anti-SFK and anti-PSD-95 in
NR2A immunoprecipitated protein. (B) BME/5-azaC treatment significantly increased interaction of NR2A with SFK, (C) and PSD-95. Data were shown as
mean ± SEM, asterisk indicates significant difference (∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001). Comparisons between groups are represented as a = Con verses
BME; b = Con verses 5-azaC; and c = BME verses 5-azaC.
(BME: r = −0.965, P < 0.001; 5-azaC: r = −0.885, P < 0.01) in
hippocampus. Overall, these data supported the idea that BME/5-
azaC treatment possibly regulated the methylation of reelin
promoter, as there was a correlation of decreased methylation
with increased mRNA level.
Effect of BME on Splicing of ApoER 2
Receptor
One could expect that, the altered reelin could contribute to the
possible changes on the target molecules. Alternative splicing
of ApoER 2 was a critical component in the reelin mediated
NMDA receptor activity. ApoER 2 (ex 19) mRNA (Figure 4A)
significantly increased in BME [F(1,11) = 23.31, P < 0.001] and
5-azaC group [F(1,11) = 31.28, P < 0.001] relative to control
group. Whereas, there was no significant difference between BME
and 5-azaC groups [F(1,11) = 0.832, P = 0.383]. Conversely, the
ApoER 2 (1) ex 19 mRNA variants were at lower level in BME
[F(1,11) = 19.35, P < 0.001] and 5-azaC groups [F(1,11) = 13.2,
P< 0.01] compared to control group, but there was no significant
difference between BME and 5-azaC groups [F(1,11) = 0.0016,
P = 0.969] (Figure 4B). Up-regulated level of ApoER 2 (ex 19)
may be linked with recorded improvement in NOR, suggesting
that ApoER 2 (ex 19) splicing possibly induced by BME treatment.
Effect of BME on Reelin Mediated NMDA
in Phosphorylation of DAB1
Reelin binding to ApoER 2 (ex 19) and VLDLR results in
activation of DAB1. To expand our understanding, we tested
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FIGURE 8 | Effect of BME/ 5-azaC on DNA methylation of BDNF promoter region. (A) BME/ 5-azaC treatment increased unmethylated DNA in BDNF
promoter region, (B) but did not alter the methylated BDNF. Data were shown as mean ± SEM, asterisk indicates significant difference (∗∗∗P < 0.001). Comparisons
between groups are represented as a = Con verses BME; b = Con verses 5-azaC; and c = BME verses 5-azaC.
whether the BME induced up-regulated ApoER 2 (ex 19)
facilitates the phosphorylation of DAB1 (p-DAB1). Total and
p-DAB1 level in Con/BME/5-azaC groups were determined.
Figures 5A,B showed that BME/5-azaC treatment significantly
increased the level of p-DAB1 in both BME [F(1,5) = 150.662,
P < 0.001] and 5-azaC [F(1,5) = 14.844, P < 0.05] compared
to control group. The level of p-DAB1 was higher in
BME [F(1,5) = 101.637, P < 0.001] than 5-azaC group.
These results suggested that increased ApoER 2 (ex19) by
BME/5-azaC was responsible for elevated levels of total and
p-DAB1.
Effect of BME on Alternation of NMDA
Receptors
We examined whether the BME treatment altered the NMDARs
subunits composition (Figure 6A). Western blot analysis showed
that the level of NR2A was significantly higher in BME
[F(1,5) = 107.05, P < 0.001] and 5-azaC [F(1,5) = 209.707,
P < 0.001] compared to control group. While comparing BME
with 5-azaC, the level of NR2A in BME [F(1,5) = 12.128,
P < 0.05] was higher than 5-azaC group (Figure 6B).
Similarly, the level of NR2B was significantly higher in BME
[F(1,5) = 42.446, P < 0.01] and 5-azaC [F(1,5) = 12.99, P < 0.05]
compared to control group. Whereas, there was no significant
difference between BME and 5-azaC groups [F(1,5) = 6.931,
P = 0.058] (Figure 6C). Therefore, the NR2A/NR2B ratio was
significantly higher in BME [F(1,5) = 100.439, P < 0.001] and 5-
azaC [F(1,5) = 103.83, P < 0.001] compared to control group.
Whereas, there was no difference between BME and 5-azaC
groups [F(1,5) = 2.919, P = 0.163] (Figure 6D). Thus BME/5-
azaC treatment increased the NMDAR (NR2) subunits and
NR2A/NR2B ratio.
Effect of BME on Interaction of NMDAR
Subunit with Synaptic Proteins
Further, our Co-IP showed that observed alternation in NR2A
level concomitantly enhanced interaction with key synaptic
proteins (Figure 7A). The analysis revealed that the level
of NR2A–SFK proteins was significantly higher in BME
[F(1,5) = 736.071, P < 0.001] than control group. Surprisingly, it
was lower in 5-azaC group compared to control [F(1,5) = 14.928,
P < 0.05] and BME [F(1,5) = 202.34, P < 0.001] (Figure 7B).
While considering the level of interacted NR2A–PSD-95 proteins,
it was significantly higher in both BME [F(1,5) = 8.44,
P < 0.05] and 5-azaC treated group [F(1,5) = 27.079,
P < 0.01] than the control group. Whereas, there was no
significant difference between BME and 5-azaC [F(1,5) = 4.56,
P = 0.100] (Figure 7C). The higher level of SFK/PSD-95
with NR2A in BME/5-azaC groups, further supported NMDAR
activation.
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FIGURE 9 | Effect of BME/5-azaC on expression of BDNF mRNA and
protein. (A) Western blot showing immunoreactivity to anti-BDNF.
(B) BME/5-azaC treatment increased BDNF mRNA levels, (C) and BDNF
protein. Data were shown as mean ± SEM, asterisk indicates significant
difference (∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001). Comparisons between
groups are represented as a = Con verses BME; b = Con verses 5-azaC; and
c = BME verses 5-azaC.
Effect of BME Mediated NMDA
Activation on Methylation and
Expression of BDNF
Further, we tested whether altered NMDAR interactions were
correlated with transcriptional and translational activity of
BDNF. First, we tested the level of methylation status of BDNF
promoter. We found that the level of unmethylated BDNF was
significantly increased in BME [F(1,5) = 592.189, P < 0.001] and
5-azaC [F(1,5) = 736.074, P< 0.001] groups compared to control
(Figure 8A). But there was no significant difference between
BME and 5-azaC groups [F(1,5) = 3.438, P = 0.137]. However,
the estimated methylated DNA in BME [F(1,5) = 0.00181,
P = 0.968] and 5-azaC [F(1,5) = 0.335, P = 0.594] groups
was not significantly different from control. Similarly, there
was no significant difference between BME and 5-azaC groups
[F(1,5) = 0.196, P = 0.681] (Figure 8B). In addition, our
analysis showed a significant positive correlation between DI and
unmethylated BDNF DNA (BME: r = 0.970, P < 0.001; 5-azaC:
r = 0.898, P < 0.01). We did not find a significant correlation
between DI and methylated BDNF DNA (BME: r = 0.034,
P = 0.936; 5-azaC: r =−0.460, P = 0.251) in hippocampus.
Subsequently, we found that level of BDNF mRNA was
significantly increased in BME [F(1,5) = 119.153, P < 0.001] and
5-azaC treated groups [F(1,5) = 342.48, P < 0.001] compared to
control group. But there was no difference between BME and 5-
azaC [F(1,5) = 0.126, P = 0.73] (Figure 9B). Supporting to this,
the western blot analysis showed that the level of BDNF protein
was significantly higher in BME [F(1,5) = 48.527, P < 0.01] and
5-azaC [F(1,5) = 25.766, P < 0.01] compared to control group,
but there was no significant difference between BME and 5-azaC
[F(1,5) = 1.866, P= 0.244] (Figures 9A,C). These data supported
that the NMDAR activation by BME/5-azaC treatment altered the
unmethylated BDNF levels and its expression.
DISCUSSION
Earlier studies demonstrated that DNA methylation/dem-
ethylation involves in the regulation of activity dependent
neuronal gene expression (Ming and Song, 2011; Baker-Andresen
et al., 2013) and synaptic plasticity (Miller and Sweatt, 2007;
Feng et al., 2010). A family of DNMTs (DNMT1, 3a, 3b) can
catalyze the process of DNA methylation (Sweatt, 2009). The
expression pattern of DNMTs (DNMT1, 3a, 3b) differ in different
brain regions following behavioral training and exhibits different
behavioral phenotype (Feng et al., 2010; Miller et al., 2010; Morris
et al., 2014). In fact, DNMT inhibitors (5-azaC) are known to
alter learning and memory/memory consolidation (Miller and
Sweatt, 2007). Considering the role of DNA methylation in
memory formation, first we showed the effect of BME in novel
object recognition by comparing with DNMT inhibitor, 5-azaC.
Using NOR test, we found that BME effectively enhanced the
NOR memory, this suggested that BME treatment improved the
process of recollection and familiarity identification (Squire et al.,
2007). It has been shown that methylation status alters rapidly
and dynamically within hippocampus (Miller and Sweatt, 2007).
The level of DNMT 3a was also significantly elevated following
contextual training in NOR test, but its conditional knock-
out impaired NOR memory (Morris et al., 2014). Observed
behavioral results suggested that BME/5-azaC treatment might
optimally regulate the DNMT 3a level at this age of rats and hence
improve NOR memory.
Following the improvement in behavioral phenotype; we
sought to correlate this with methylation status. As quantified
by RT-PCR, a higher level of unmethylated and lower level of
methylated reelin DNA was estimated in BME and 5-azaC treated
groups when compared to control. Supporting this, earlier studies
have shown that 5-azaC treatment reduces the methylated DNA
in reelin promoter (Miller and Sweatt, 2007; Sui et al., 2012).
Consistent with the demethylation status, the level of reelin
mRNA was significantly elevated in both BME and 5-azaC treated
rats. The positive correlation between recognition memory (DI)
and unmethylated reelin DNA in BME/5-azaC group suggested
that BME possibly regulated methylation to enhance memory.
These results are in line with earlier reports on methylation status
and expression of reelin during neural plasticity (Levenson et al.,
2006; Miller and Sweatt, 2007). In addition, observed behavioral
data may be linked with the up-regulated reelin expression
(Rogers et al., 2011) and increased dendritic spine density in
hippocampus (Vollala et al., 2011).
Reelin exerts its effects through ApoER 2 ex 19 receptor
(Weeber et al., 2002; Beffert et al., 2005). Interestingly, BME/
5-azaC treatment up-regulated the ApoER 2 (exon 19) variant
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and down-regulated ApoER 2(1) transcript. The up-regulated
ApoER 2 exon 19 attaches to postsynaptic density protein PSD-
95 and forms a signaling complex with NMDARs (Beffert et al.,
2005; Hoe et al., 2006). However, to execute the neuronal
transmission, NMDAR should be activated by p-DAB1 (Chen
et al., 2005; Beffert et al., 2006). Consistently, BME/5-azaC
treatment enhanced the level of p-DAB1. In process p-DAB1
activates Src kinase family (SFK) through phosphorylation,
which in turn leads to phosphorylation of NMDAR subunit
(NR2) (Ballif et al., 2003; Bock and Herz, 2003; Strasser
et al., 2004; Chen et al., 2005; Mota et al., 2014). However,
synaptic strength is determined by the ratio of NMDAR
subunits (NR2A/NR2B) (Quinlan et al., 2004; Lebel et al., 2006;
Brigman et al., 2008; Levenson et al., 2008). In this study,
the level of NR2A and NR2B subunits and the estimated
NR2A/NR2B ratio were higher in BME and 5-azaC groups
compared to control. In addition, the co-immunoprecipitation
studies further substantiate our hypothesis and showed enhanced
interaction of NR2A subunit with SFK and PSD-95 in BME
and 5-azaC groups compared to control group. This complex
possibly enhances the Ca2+ influx through the release of
glutamate, and then induces LTP and LTM (Chen et al.,
2005; Qiu et al., 2006). Further, the activated NMDAR is
in turn found to mediate events associated with methylation
of BDNF and its subsequent regulation of transcripts and
translation in the hippocampus during LTM. We found that
level of unmethylated BDNF DNA was higher in BME and
5-azaC groups compared to control. Subsequently, the level
of Bdnf (exon IV) mRNA and protein were found to be
higher in BME and 5-azaC groups compared to control. There
could be a possible correlation of unmethylated BDNF with its
expression. However, we did not find a significant difference in
the level of methylated form (Martinowich et al., 2003; Munoz
et al., 2010). Interestingly, we observed a positive correlation
between DI with unmethylated BDNF DNA in BME/5-azaC
group. BME/5-azaC possibly regulate the exon specific expression
by controlling methylation process (Sales et al., 2011), and
the expression of BDNF in hippocampus enhances memory
(Bekinschtein et al., 2007, 2008a,b; Lubin et al., 2008; Mizuno
et al., 2012).
Taken together, we have shown the effect of BME in the
regulation of DNA methylation using known reelin-dependent
NMDAR–BDNF signaling. Our results show that the BME
treatment dynamically controlled the methylation of reelin and
subsequent alternative splicing of ApoER 2. Further, it might be
implicated in the activation and interaction of NMDAR with
synaptic protein (PSD-95) to induce BDNF. This mechanism
might contribute to the modulation of synaptic plasticity and thus
to enhance learning and memory.
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